Published in Pharma Investments, Ventures and Law Weekly, October 1st, 2006
The applications will directly support Broin and Associates proprietary BPX technologies for ethanol production. Terms of the agreement were not disclosed.
Earlier this year, SDI announced the publication of its patent application, including claims addressing problems in bio-fermentation that pertain to the microbiological contamination of the process.
Process contamination is a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.